Cerity Partners LLC Boosts Stake in GE HealthCare Technologies Inc. $GEHC

Cerity Partners LLC grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 20.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 373,570 shares of the company’s stock after acquiring an additional 64,017 shares during the quarter. Cerity Partners LLC owned about 0.08% of GE HealthCare Technologies worth $28,055,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Glenview Trust co raised its holdings in GE HealthCare Technologies by 4.4% in the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock valued at $266,000 after buying an additional 139 shares during the period. True North Advisors LLC increased its position in shares of GE HealthCare Technologies by 2.0% in the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after acquiring an additional 139 shares in the last quarter. Silver Oak Securities Incorporated increased its position in shares of GE HealthCare Technologies by 4.6% in the second quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock worth $236,000 after acquiring an additional 140 shares in the last quarter. Chicago Capital LLC raised its stake in shares of GE HealthCare Technologies by 2.2% in the 2nd quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock valued at $485,000 after acquiring an additional 141 shares during the period. Finally, Fort Washington Investment Advisors Inc. OH lifted its holdings in shares of GE HealthCare Technologies by 4.2% during the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock valued at $263,000 after acquiring an additional 143 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Up 2.8%

GEHC stock opened at $88.16 on Friday. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. The firm has a 50 day simple moving average of $80.05 and a 200-day simple moving average of $76.55. The company has a market capitalization of $40.16 billion, a P/E ratio of 18.21, a PEG ratio of 3.34 and a beta of 1.08. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The firm had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The firm’s revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.89%.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on GEHC shares. BTIG Research reiterated a “buy” rating and issued a $87.00 price target on shares of GE HealthCare Technologies in a report on Friday, November 21st. Morgan Stanley increased their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Barclays assumed coverage on GE HealthCare Technologies in a research report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price target on the stock. Finally, Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Seven investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies has an average rating of “Moderate Buy” and an average target price of $88.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.